AFREXIM Bank To Deliver 40m Doses Of J&J Vaccines To Nigeria By 2022
Vice President Yemi Osinbajo, SAN has commended the African Export-Import Bank (AFREXIM) for its efforts in stimulating and developing African trade, including its many engagements in Nigeria.
Prof. Osinbajo made the observation today at the Presidential Villa while interacting with a delegation from the bank led by its President, Prof. Benedict Oramah.
Speaking after receiving a brief on the bank’s activities as well as ongoing projects in the country, the Vice President expressed satisfaction with the work done by the bank and the interest shown in areas such as health infrastructure, trade facilitation and tourism, among others.
According to Oramah, AFREXIM is investing in trade and health infrastructure, and is also involved in the procurement and distribution of COVID-19 vaccines to African countries including Nigeria, to enable the continent achieve herd immunity.
The bank is also planning to establish National Quality Assurance Centres in parts of the country in order to support and upgrade export of commodities from Nigeria.
Referencing the planned establishment of quality assurance centres across the country, the VP said it is important because “one of the problems we have had with our exports is really this problem of quality assurance and making sure that we have the facilities to test our export products and get all of our agencies working together.
Earlier in his presentation, Prof. Oramah said AFREXIM has plans of investing in important sectors of the Nigerian economy including health, citing plans to build a world class tertiary hospital and health park in Abuja. He said the 500-bed state-of-the-art hospital will be developed in collaboration with Kings College Hospital in the UK, and other partners.
The CEO also disclosed an arrangement under the AFREXIM Bank facility to deliver 40 million doses of the Johnson & Johnson COVID-19 vaccines to Nigeria over a short period of time.
He added that the bank was committed to ensuring that the continent achieved herd immunity by vaccinating about 60% of Africa’s population against the disease.
